If We Need More Time, Is an Extension Better Than Withdrawing and Reapplying for Accreditation?
Reviewed November 2026
Withdrawal offers no documented timing advantage in the reviewed ACHC and NABP materials; in IHS's reading, compare preservation terms before giving up the application. Have IHS draft a written question on your withdrawal terms; you send it.
For an organization needing about two more months, the comparison starts with what would end: an unfinished application, a survey booking, or existing accreditation. In IHS's reading, these are separate decisions: a changed deadline does not establish that current status continues, and a fresh application does not establish an earlier award.
What would ACHC postponement preserve, and what could we forfeit?
Under ACHC's dated documents, an accepted postponement leads to rescheduling once the organization reports readiness in writing; missing that notice within 180 days risks losing both application and deposit. ACHC's Specialty Pharmacy process revised April 4, 2023, and DMEPOS process revised April 15, 2021, require a written request to the Account Advisor, subject to ACHC acceptance. An accepted request carries a charge payable before rescheduling. The readiness clock starts on postponement; forfeiture requires reapplication. These are survey-postponement provisions, not an application extension. The documents provide no separate application-extension provision.
In IHS's reading, that forfeiture ends the pending application and loses its deposit; it is more than a changed booking. The cited provisions give no restart duration or separate voluntary-withdrawal entitlement. Ask which current agreement controls and whether completed reviews would survive withdrawal.
Those dated documents switch to the refusal procedure on an unannounced survey's day, or the day before an announced survey.
Would restarting a NABP application buy us two more months?
NABP's Application Guide and DMEPOS apply page do not promise two more months through withdrawal. Its Application Guide deletes an application still unsubmitted or unpaid after 60 days; the saved content cannot be recovered. A replacement application is necessary. Separately, failure to supply requested missing information within 30 days cancels a submitted application. Withdrawal or cancellation brings a handling charge. Refunds follow the particular program's policy.
NABP's Specialty Pharmacy pricing page lists requests for extra time among events that may bring additional fees. The Application Guide gives no extension procedure or approver.
The DMEPOS apply page describes review of policies and supporting documents, license checks and an unannounced survey. Neither document gives an end-to-end restart duration. In IHS's reading, ask NABP what work would carry forward before treating a new application as extra preparation time.
Does CARF extend an application or existing accreditation?
CARF's 2026 Continuing Care Retirement Community manual addresses extending existing accreditation only; the CARF sources reviewed give no initial-application extension. CARF decides whether to grant a CCRC extension. The manual says a written request with its rationale should come before the timely resurvey application. No extension is approved before that application is filed, and extensions generally do not exceed three months. Late filing risks a lapse.
For CCRC surveys, cancellation after scheduling notice carries a charge and nonrefundable travel expenses. Overdue debt prevents acceptance of another application until paid. Ask CARF what your voluntary withdrawal would close and what obligations would remain.
CARF's general steps page says preparation can take a year or longer, but supplies no withdrawal-to-new-award duration. In IHS's reading, that preparation estimate cannot establish a restart duration.
Can we ask URAC for an extension instead of withdrawing?
You can ask while you are in the application process: URAC's public FAQ says an organization in that process can request an extension, that URAC approves each request case by case and may charge an added fee, and that the request starts with the Lead Reviewer or the Client Relations Manager. The same FAQ says an organization that does not earn accreditation receives no refund. It gives no extension length and says nothing about what withdrawal ends, whether a withdrawing applicant is refunded or how long a restart takes (https://www.urac.org/accreditations-certifications/accreditation-faqs/, read Nov 2, 2026).
Could withdrawing affect Medicare status or billing?
Withdrawing existing accreditation can remove Medicare deemed status for deemed providers and suppliers other than CLIA; losing required DMEPOS accreditation has a separate billing consequence. For those non-CLIA providers and suppliers, CMS's State Operations Manual directs removal of deemed status after accreditation termination or voluntary withdrawal unless another CMS-approved Medicare accreditation supports it. State Survey Agency oversight follows removal.
CMS's Program Integrity Manual directs contractors to revoke an enrolled DMEPOS supplier's billing privileges when required accreditation is not maintained; this concerns suppliers subject to accreditation, not exempt suppliers.
In IHS's reading, distinguish abandoning a pending initial application from surrendering accreditation already supporting participation. Removal of deemed status is not, by itself, the same instruction as automatic termination of Medicare participation. Have counsel assess the actual status and effective dates before withdrawal.
Does Medicare's section 488.8(g) give us a grace period if we withdraw?
No, not under section 488.8(g) as reviewed: it gives a provider choosing withdrawal none of the grace period described there. Its conditional 180-day continuation concerns CMS removing approval of an accreditor's program or the accreditor terminating that program. It requires an application to another approved program and notice to the State Survey Agency within the applicable 60-day period.
Section 488.5(a)(4)(i) separately requires approved accreditors to agree to unannounced resurveys within 36 months, or a shorter statutory interval. In IHS's reading, neither provision grants an individual applicant two extra months. Ask which provision governs your exact event; an accreditor's program ending and your organization withdrawing are different events.
What questions decide whether either path solves our delay?
Compare the paths in this order: your agreement, the accreditor's earliest completion sequence, any payer or state date, then what two months would finish. First, check your agreement: who can authorize more time, what does withdrawal end, what survives, and which evidence or reviews must be repeated? Second, ask the accreditor for the earliest supportable completion sequence under each option, without assuming an award date.
Third, read each applicable state notice and payer contract: does its date concern submission, an accreditation award, or uninterrupted status? Who can change that date? Finally, name the missing record or review that two months would complete. This is IHS's decision framework, not an accreditor's rule or a recommendation to extend or withdraw.
What this is NOT
This is not legal advice or a determination of your contractual rights.
This is not a promise of approval, a restart timetable, or confirmation that the dated ACHC terms govern your agreement today.
This does not extend CCRC policies to other CARF programs or decide any state or payer deadline.
Frequently asked questions
Do we need a consultant to compare the options?
No, if your team can read the governing documents and build the comparison itself. IHS can map remaining work and draft questions; counsel adds interpretation where contract language or legal consequences are disputed.
Who sends the request or withdrawal?
Your organization sends it. IHS drafts for your review and approval. IHS never contacts, submits to, confirms with, or represents a client before an accreditor, regulator or payer.
About the author
Thomas G. Goddard, JD, PhD, has been Chief Executive Officer of Integral Healthcare Solutions since 2002. He was Chief Operating Officer and General Counsel of URAC from 1998 to 2000.
Integral Healthcare Solutions: accreditation consulting, compliance services, and program development.
Sources
The following primary sources support the program-specific comparison above.
Specialty Pharmacy Accreditation Process, revised April 4, 2023, IV.G. Accreditation Commission for Health Care. https://achcu.com/wp-content/uploads/2023/06/ACHCU-Specialty-Pharmacy-Process.pdf
DMEPOS Accreditation Process, revised April 15, 2021, IV.G. Accreditation Commission for Health Care. https://achcu.com/wp-content/uploads/2022/05/DMEPOS-Accreditation-Process-2022.pdf
Application Guide, pages 6 and 18. National Association of Boards of Pharmacy. https://nabpfiles.s3.amazonaws.com/Application%20Guide.pdf
Apply for DMEPOS Pharmacy Accreditation. National Association of Boards of Pharmacy. https://nabp.pharmacy/programs/accreditations/dmepos-pharmacy/apply/
Steps to accreditation. CARF International. https://carf.org/accreditation/steps-accreditation/
2026 Continuing Care Retirement Community Standards Manual, pages 14–15 and 21–22. CARF International. https://carf.org/wp-content/uploads/2026/02/2026-CCRC-SM.pdf
State Operations Manual, Chapter 2, section 2005B. Centers for Medicare & Medicaid Services. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107c02.pdf
42 CFR 488.5(a)(4)(i). Centers for Medicare & Medicaid Services; eCFR. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-488/subpart-A/section-488.5
42 CFR 488.8(g). Centers for Medicare & Medicaid Services; eCFR. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-488/subpart-A/section-488.8
Medicare Program Integrity Manual, Chapter 10, section 10.2.5.1. Centers for Medicare & Medicaid Services. https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/pim83c10.pdf
Specialty Pharmacy accreditation pricing page, National Association of Boards of Pharmacy (NABP), listing occurrences for which additional fees may be assessed. https://nabp.pharmacy/accreditation-inspections-pricing/specialty-pharmacy/
Accreditation FAQs. URAC. https://www.urac.org/accreditations-certifications/accreditation-faqs/ (read Nov 2, 2026)
Last updated: November 6, 2026. Listed sources were retrieved October 31, 2026, except the URAC FAQ, read Nov 2, 2026; the Reviewed November 2026 label reflects that source review. Requirements change and must be verified with the issuing body.